• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于壳聚糖的颗粒作为控释药物递送系统。

Chitosan-based particles as controlled drug delivery systems.

作者信息

Prabaharan M, Mano J F

机构信息

Biomaterials, Biodegradables and Biomimetics, Department of Polymer Engineering, University of Minho, Guimaraes, Portugal.

出版信息

Drug Deliv. 2005 Jan-Feb;12(1):41-57. doi: 10.1080/10717540590889781.

DOI:10.1080/10717540590889781
PMID:15801720
Abstract

Chitosan, a natural-based polymer obtained by alkaline deacetylation of chitin, is nontoxic, biocompatible, and biodegradable. These properties make chitosan a good candidate for conventional and novel drug delivery systems. This article reviews the approaches aimed to associate bioactive molecules to chitosan in the form of colloidal structures and analyzes the evidence of their efficacy in improving the transport of the associated molecule through mucosae and epithelia. Chitosan forms colloidal particles and entraps bioactive molecules through a number of mechanisms, including chemical crosslinking, ionic crosslinking, and ionic complexation. A possible alternative of chitosan by the chemical modification also has been useful for the association of bioactive molecules to polymer and controlling the drug release profile. Because of the high affinity of chitosan for cell membranes, it has been used as a coating agent for liposome formulations. This review also examines the advances in the application of chitosan and its derivatives to nonviral gene delivery and gives an overview of transfection studies that use chitosan as a transfection agent. From the studies reviewed, we concluded that chitosan and its derivatives are promising materials for controlled drug and nonviral gene delivery.

摘要

壳聚糖是一种通过甲壳素碱性脱乙酰化获得的天然聚合物,无毒、生物相容且可生物降解。这些特性使壳聚糖成为传统和新型药物递送系统的理想选择。本文综述了旨在将生物活性分子以胶体结构形式与壳聚糖结合的方法,并分析了它们在改善相关分子通过黏膜和上皮细胞转运方面有效性的证据。壳聚糖通过多种机制形成胶体颗粒并包封生物活性分子,包括化学交联、离子交联和离子络合。通过化学修饰对壳聚糖进行的一种可能替代方法也有助于将生物活性分子与聚合物结合并控制药物释放曲线。由于壳聚糖对细胞膜具有高亲和力,它已被用作脂质体制剂的包衣剂。本综述还考察了壳聚糖及其衍生物在非病毒基因递送应用方面的进展,并概述了使用壳聚糖作为转染剂的转染研究。从所综述的研究中,我们得出结论,壳聚糖及其衍生物是用于可控药物和非病毒基因递送的有前景的材料。

相似文献

1
Chitosan-based particles as controlled drug delivery systems.基于壳聚糖的颗粒作为控释药物递送系统。
Drug Deliv. 2005 Jan-Feb;12(1):41-57. doi: 10.1080/10717540590889781.
2
Review paper: chitosan derivatives as promising materials for controlled drug delivery.综述论文:壳聚糖衍生物作为可控药物递送的有前景材料
J Biomater Appl. 2008 Jul;23(1):5-36. doi: 10.1177/0885328208091562.
3
Polysaccharide colloidal particles as delivery systems for macromolecules.
Adv Drug Deliv Rev. 2001 Mar 23;47(1):83-97. doi: 10.1016/s0169-409x(00)00123-x.
4
Chitosan-based gastrointestinal delivery systems.基于壳聚糖的胃肠道给药系统。
J Control Release. 2003 Apr 29;89(2):151-65. doi: 10.1016/s0168-3659(03)00126-3.
5
An overview of carboxymethyl derivatives of chitosan: Their use as biomaterials and drug delivery systems.壳聚糖羧甲基衍生物概述:其作为生物材料和药物递送系统的应用。
Mater Sci Eng C Mater Biol Appl. 2017 Aug 1;77:1349-1362. doi: 10.1016/j.msec.2017.03.198. Epub 2017 Mar 23.
6
Chitosan-based formulations for delivery of DNA and siRNA.基于壳聚糖的 DNA 和 siRNA 递释系统。
Adv Drug Deliv Rev. 2010 Jan 31;62(1):12-27. doi: 10.1016/j.addr.2009.08.004. Epub 2009 Sep 29.
7
Casein-based formulations as promising controlled release drug delivery systems.基于酪蛋白的配方作为有前途的控释药物传递系统。
J Control Release. 2011 Aug 10;153(3):206-16. doi: 10.1016/j.jconrel.2011.02.010. Epub 2011 Feb 19.
8
Chitosan: a propitious biopolymer for drug delivery.壳聚糖:一种用于药物递送的优良生物聚合物。
Curr Drug Deliv. 2015;12(4):369-81. doi: 10.2174/1567201812666150310151657.
9
Efficient gene delivery by urocanic acid-modified chitosan.尿刊酸修饰壳聚糖实现高效基因递送
J Control Release. 2003 Dec 12;93(3):389-402. doi: 10.1016/j.jconrel.2003.08.017.
10
A review on chitosan and its nanocomposites in drug delivery.壳聚糖及其纳米复合材料在药物传递中的研究进展综述。
Int J Biol Macromol. 2018 Apr 1;109:273-286. doi: 10.1016/j.ijbiomac.2017.12.078. Epub 2017 Dec 14.

引用本文的文献

1
Chitosan-based Biomaterials in Regenerative Medicine: Optimizing Mesenchymal Stem Cell Viability and Function.再生医学中基于壳聚糖的生物材料:优化间充质干细胞的活力与功能
Stem Cell Rev Rep. 2025 Jul 24. doi: 10.1007/s12015-025-10901-z.
2
Chitosan-based formulations for therapeutic applications. A recent overview.用于治疗应用的基于壳聚糖的制剂。近期综述。
J Biomed Sci. 2025 Jul 8;32(1):62. doi: 10.1186/s12929-025-01161-7.
3
Kinetic Study of Release of Neem from Chitosan Biopolymer and Assessment of Its Biological Effectiveness.
印楝从壳聚糖生物聚合物中释放的动力学研究及其生物学有效性评估。
Polymers (Basel). 2025 Mar 6;17(5):702. doi: 10.3390/polym17050702.
4
Chitosan as a Plurivalent Biopolymer in Nanodelivery Systems.壳聚糖作为纳米递送系统中的多价生物聚合物
Polymers (Basel). 2025 Feb 20;17(5):558. doi: 10.3390/polym17050558.
5
Enhancing the Therapeutic Effect and Bioavailability of Irradiated Silver Nanoparticle-Capped Chitosan-Coated Rosuvastatin Calcium Nanovesicles for the Treatment of Liver Cancer.增强辐照银纳米颗粒包覆的壳聚糖包被瑞舒伐他汀钙纳米囊泡治疗肝癌的疗效和生物利用度。
Pharmaceutics. 2025 Jan 7;17(1):72. doi: 10.3390/pharmaceutics17010072.
6
Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.叶酸修饰壳聚糖纳米粒:新一代抗癌纳米载体。
Mol Cancer. 2024 Oct 31;23(1):244. doi: 10.1186/s12943-024-02163-z.
7
Effect of Crosslinking Agents on Chitosan Hydrogel Carriers for Drug Loading and Release for Targeted Drug Delivery.交联剂对用于靶向给药的载药及释药壳聚糖水凝胶载体的影响。
Gels. 2024 Jun 26;10(7):421. doi: 10.3390/gels10070421.
8
Carboxymethylcellulose encapsulated fingolimod, siRNA@ZnO hybrid nanocomposite as a new anti-Alzheimer's material.羧甲基纤维素包裹的芬戈莫德、siRNA@ZnO杂化纳米复合材料作为一种新型抗阿尔茨海默病材料。
RSC Adv. 2024 Jul 12;14(30):22044-22055. doi: 10.1039/d4ra01965b. eCollection 2024 Jul 5.
9
3D-Printed Chitosan-Based Scaffolds with Extract for Dental Applications.用于牙科应用的含提取物的3D打印壳聚糖基支架
Pharmaceutics. 2024 Mar 4;16(3):359. doi: 10.3390/pharmaceutics16030359.
10
Preparation, Characterization, and Hepatoprotective Activity Evaluation of Quercetin-loaded Pluronic F127/Chitosan-Myristic Acid Mixed Micelles.载槲皮素的泊洛沙姆F127/壳聚糖-肉豆蔻酸混合胶束的制备、表征及肝保护活性评价
Curr Drug Deliv. 2025;22(6):761-783. doi: 10.2174/0115672018278618240304054731.